Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
Indometacin Sodium in Modified Natural-Cycle IVF: RCT Insigh
2026-07-16
This article examines a randomized controlled trial evaluating indometacin sodium for reducing premature ovulation in modified natural-cycle IVF. The study reveals nuanced outcomes, highlighting a significant benefit in a specific patient subgroup, and informs future research and clinical applications in reproductive medicine.
-
ω-Agatoxin IVA TFA: Redefining Neuroprotection and Epilepsy
2026-07-16
Explore how ω-Agatoxin IVA TFA advances neuroprotection and epilepsy research through precise Cav2.1 channel inhibition. This article delivers in-depth analysis of recent mechanistic breakthroughs, practical protocols, and translational insights beyond standard usage guides.
-
Folic Acid Mitigates T. gondii Antigen-Induced Vascular Inju
2026-07-15
This study demonstrates that soluble antigens from Toxoplasma gondii can directly compromise vascular integrity by reprogramming endothelial cells through the CD36-autophagy-lysosomal axis. Importantly, folic acid acts prophylactically to suppress this pathogenic mechanism, revealing new therapeutic angles for infection-associated vascular injury.
-
Pharmacological SMYD2 Inhibition Mitigates Cisplatin-Induced
2026-07-15
This study demonstrates that pharmacological inhibition of SMYD2 with agents such as LLY-507 protects against cisplatin-induced renal fibrosis and inflammation. The findings reveal novel mechanistic insights into SMYD2's role in chronic kidney disease and provide a foundation for future therapeutic strategies targeting epigenetic regulators.
-
Dibutyryl-cAMP, Sodium Salt: Advancing Neuronal Reprogrammin
2026-07-14
Explore how Dibutyryl-cAMP, sodium salt enables precise modulation of cAMP signaling to enhance neuronal reprogramming and cell fate conversion. Gain new insights into its mechanistic role, protocol optimization, and translational implications beyond standard applications.
-
GRK Subtype-Specific Modulation of M1 Receptor Biased Signal
2026-07-14
This study delineates how distinct G protein-coupled receptor kinase (GRK) subtypes govern biased signaling of the M1 muscarinic acetylcholine receptor (mAChR), using quantitative BRET assays with both orthosteric agonists and allosteric modulators such as BQCA. The mechanistic insights into GRK-dependent regulation of G protein and β-arrestin coupling have important implications for rational design of cognitive function and Alzheimer's disease research tools.
-
Benzyl Quinolone Carboxylic Acid (BQCA): Reliable M1 Recepto
2026-07-13
This article provides an evidence-based, scenario-driven guide to deploying Benzyl Quinolone Carboxylic Acid (BQCA, SKU C3869) in cell signaling and neurodegeneration assays. Laboratory challenges in M1 muscarinic receptor research are addressed using validated protocols and data from APExBIO's high-purity offering, highlighting workflow reproducibility, selectivity, and practical optimization for Alzheimer's disease and cognitive function studies.
-
A 6C Medium Extends Mouse Corneal Epithelial Cell Proliferat
2026-07-13
The referenced study introduces a novel, serum-free 6C medium that significantly extends the proliferative capacity of mouse corneal epithelial cells (mCECs) both in vitro and in vivo. This innovation enables efficient expansion of progenitor cells for corneal transplantation and offers new avenues for studying mechanisms of epithelial renewal and transdifferentiation.
-
Omeprazole (A2845): Technical Use in Gastric Acid Research
2026-07-12
Omeprazole (SKU A2845) is a potent H+,K+-ATPase inhibitor tailored for research on gastric acid secretion and antiulcer mechanisms. It should only be used in controlled laboratory workflows, not for diagnostic or therapeutic applications, due to stability, solubility, and intended-use boundaries.
-
Cy5.5 NHS Ester: Illuminating Translational Pathways in NIR
2026-07-10
Explore how Cy5.5 NHS ester (non-sulfonated) is redefining sensitive, multiplexed in vivo imaging and biomolecule labeling. This thought-leadership article blends mechanistic insight, recent advances in polysaccharide bioactivity tracking, and actionable guidance for translational researchers seeking competitive, reproducible fluorescence strategies.
-
2-D08 (2’,3’,4’-trihydroxyflavone): Reliable Sumoylation Inh
2026-07-09
This article presents scenario-driven guidance for using 2-D08 (2’,3’,4’-trihydroxyflavone) (SKU C4445) in cell-based sumoylation and cytotoxicity assays. Learn how reproducibility, selectivity, and validated protocols from APExBIO empower researchers to address complex posttranslational modification workflows with confidence.
-
I-BET151 (GSK1210151A): Transforming BET Inhibition in Cance
2026-07-09
I-BET151 (GSK1210151A) enables precise, reproducible dissection of BET-driven transcriptional programs in cancer models, supporting robust apoptosis and cell cycle arrest workflows. Leveraging recent insights into super-enhancer regulation and disulfidptosis, this article provides actionable guidance for experimental design, troubleshooting, and optimization with APExBIO's trusted reagent.
-
Bifendate (DDB): Advanced Workflows for Hepatoprotection Res
2026-07-08
Bifendate (DDB) offers precise, multi-targeted hepatoprotection and lipid regulation for both in vitro and in vivo liver research. This guide distills the latest experimental protocols, troubleshooting insights, and actionable findings from cutting-edge studies to empower robust experimental design and reproducibility.
-
EPI-001: Androgen Receptor N-Terminal Domain Inhibitor Workf
2026-07-08
EPI-001, a first-in-class androgen receptor N-terminal domain inhibitor, empowers researchers to address resistance in prostate and triple-negative breast cancer models. Discover how to optimize protocols, interpret molecular readouts, and avoid common pitfalls when leveraging EPI-001 for AR pathway dissection.
-
BCECF-AM: Ratiometric Intracellular pH Probe for Live Cells
2026-07-07
BCECF-AM is a cell membrane-permeable fluorescent probe for ratiometric intracellular pH measurement. Its unique acetoxymethyl ester structure enables efficient cellular uptake and rapid esterase-mediated activation, supporting sensitive live-cell imaging across mammalian, plant, and microbial systems. APExBIO provides BCECF-AM (B5370) at 98% purity for robust, reproducible assays.